The Hydrus Microstent is a revolutionary therapy used during cataract surgery to help manage your glaucoma. It has been proven in global clinical trials to lower eye pressure, which resulted in a reduction of glaucoma medicine and, in some patients, eliminated the need for medication.1
Your cataract surgery will improve the clarity of your vision. Minimally invasive glaucoma surgery (MIGS) is performed at the same time as your cataract surgery and may help to decrease your eye pressure and reduce or eliminate your need for glaucoma medications.